參考文獻/References:
[1] SEHAT K R,EVANS R,NEWMAN J H.How much blood is really lost in total knee arthroplasty?Correct blood loss management should take hidden loss into account[J].Knee,2000,7(3):151-155.
[2] GROSS J B.Estimating allowable blood loss:corrected for dilution[J].Anesthesiology,1983,58(3):277-280.
[3] NADLER S B,HIDALGO J H,BLOCH T.Prediction of blood volume in normal human adults[J].Surgery,1962,51(2):224-232.
[4] JU H,HART R A.Hidden blood loss in anterior lumbar interbody fusion(ALIF)surgery[J].Orthop Traumatol Surg Res,2016,102:67-70.
[5] LEI F,LI Z,HE W,et al.Total and hidden blood loss between open posterior lumbar interbody fusion and transforaminal lumbar interbody fusion by Wiltse approach[J].Medicine(Baltimore),2020,99(20):e19864.
[6] LEI F,LI Z,HE W,et al.Hidden blood loss and the risk factors after posterior lumbar fusion surgery:a retrospective study[J].Medicine(Baltimore),2020,99(19):e20103.
[7] XU D,CHEN X,LI Z,et al.Tranexamic acid reduce hidden blood loss in posterior lumbar interbody fusion(PLIF)surgery[J].Medicine(Baltimore),2020,99(11):e19552.
[8] 王峰,王靜成,南利平,等.氨甲環(huán)酸應用于腰椎后路椎間融合術的安全性和有效性[J].中國脊柱脊髓雜志,2019,29(5):422-430.
[9] 班正濤,劉汝專.腰椎椎間融合術后隱性失血的研究進展[J].中國骨傷,2018,31(11):1077-1080.
[10] ERSKINE J G,FRASER C,SIMPSON R,et al.Blood loss with knee joint replacement[J].J R Coll Surg Edinb,1981,26(5):295-297.
[11] BAI B,TIAN Y,ZHANG Y L,et al.Prediction of hidden blood loss during posterior spinal surgery[J].Chin Med Sci J,2019,34(1):38-44.
[12] REN Z,LI S,SHENG L,et al.Topical use of tranexamic acid can effectively decrease hidden blood loss during posterior lumbar spinal fusion surgery:a retrospective study[J].Medicine(Baltimore),2017,96(42):e8233.
[13] PENG Y J,FAN Z Y,WANG Q L,et al.Comparison of the total and hidden blood loss in patients undergoing single-level open and unilateral biportal endoscopic transforaminal lumbar interbody fusion:a retrospective case control study[J].BMC Musculoskelet Disord,2023,24(1):295.
[14] 胡攀,胡月.脊柱手術圍手術期隱性失血的研究進展[J].中醫(yī)正骨,2019,31(4):52-55.
[15] 張圣飛,張亮,張志強,等.PLIF手術隱性失血危險因素分析[J].實用骨科雜志,2018,24(8):673-676.
[16] 馬明領,馬子健,董輝,等.改良后入路腰椎體間融合術隱性失血的影響因素分析[J].臨床醫(yī)學研究與實踐,2023,8(8):9-12.
[17] 唐安樂,俞海明,陳志欽,等.腰椎退行性病斜外側椎間融合隱性失血的相關因素[J].中國矯形外科雜志,2022,30(11):979-982.
[18] WEN L,JIN D,XIE W,et al.Hidden blood loss in posterior lumbar fusion surgery:an analysis of risk factors[J].Clin Spine Surg,2018,31(4):180-184.
[19] 李蘇成,傅棟銘,李然,等.骨質疏松癥對后入路腰椎椎體間融合術患者圍手術期隱性失血的影響[J].骨科臨床與研究雜志,2021,6(5):275-279.
[20] MIMA Y,YAGI M,SUZUKI S,et al.Hidden blood loss in extreme lateral interbody fusion for adult spinal deformity[J].J Orthop Sci,2023,28(3):509-514.
[21] ZHU L,ZHANG L,SHAN Y,et al.Analysis of hidden blood loss and its risk factors in oblique lateral interbody fusion surgery[J].Clin Spine Surg,2021,34(9):E501-E505.
[22] ABE T,MIYAZAKI M,SAKO N,et al.Efficacy of gelatin-thrombin matrix sealants for blood loss in single-level transforaminal lumbar interbody fusion[J].Medicine(Baltimore),2023,102(36):e34667.
[23] 王沛,強曉軍,李原,等.MIS-TLIF術的隱性失血情況及其風險因素分析[J].頸腰痛雜志,2023,44(2):162-166.
[24] GE M,ZHANG Y,YING H,et al.Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion[J].Int Orthop,2022,46(9):2063-2070.
[25] HUANG X,WANG W,CHEN G,et al.Comparison of surgical invasiveness,hidden blood loss,and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease:a retrospective cohort study[J].BMC Musculoskelet Disord,2023,24(1):274.
[26] OLMOS M,HERNANDEZ N S,KANTER M,et al.Periprocedural polypharmacy in lumbar fusions performed under spinal anesthesia compared with general anesthesia[J].Neurosurgery,2023,92(3):632-638.
[27] LI Z,LONG H,HUANG F,et al.Impact of epidural versus general anesthesia on major lumbar surgery in elderly patients[J].Clin Spine Surg,2019,32(1):E7-E12.
[28] 符碧峰,李遠棟,劉愛峰,等.脊柱外科圍手術期輔助止血方法的研究進展[J].上海醫(yī)學,2023,46(1):54-59.
[29] 周慧,周立燕,王學麗,等.氨甲環(huán)酸和間斷負壓引流對腰椎術后引流量的影響[J].中國矯形外科雜志,2019,27(11):1001-1004.
[30] 趙勇,申才佳,張欣.不同術后引流方式在腰椎融合手術中的應用比較[J].頸腰痛雜志,2019,40(2):256-257.
[31] 謝錦偉,廖刃,向兵,等.骨科加速康復圍術期患者血液管理進展:現(xiàn)狀與未來[J].中國科學:生命科學,2022,52(11):1704-1714.
[32] CAO S,LV K,PENG C,et al.Efficacy and safety of erythropoietin in isolated spinal metastasis patients with total en bloc spondylectomy surgery:a case-control study[J].Eur Spine J,2023,32(3):1021-1028.
[33] 陶崑,黃哲宇,趙立明,等.氨甲環(huán)酸在股骨頸骨折全髖關節(jié)置換圍手術期的應用[J].中華骨與關節(jié)外科雜志,2023,16(7):596-600.
[34] WANG W,DUAN K,MA M,et al.Tranexamic acid decreases visible and hidden blood loss without affecting prethrombotic state molecular markers in transforaminal thoracic interbody fusion for treatment of thoracolumbar fracture-dislocation[J].Spine(Phila Pa 1976),2018,43(13):E734-E739.
[35] HUI S,TAO L,MAHMOOD F,et al.Tranexamic acid in reducing gross hemorrhage and transfusions of spine surgeries(TARGETS):study protocol for a prospective,randomized,double-blind,non-inferiority trial[J].Trials,2019,20(1):125.
[36] 謝明華,盧政好,歐軍.氨甲環(huán)酸不同給藥途徑在單節(jié)段腰椎后路手術中的應用觀察[J].湖北民族大學學報(醫(yī)學版),2022,39(2):45-48.
[37] 張東風,吳小東,孔清泉,等.靜脈應用不同劑量氨甲環(huán)酸對微創(chuàng)小切口經椎間孔腰椎椎間融合術圍術期失血量影響的前瞻性隨機對照研究[J].中國修復重建外科雜志,2022,36(4):439-445.
[38] MU X,WEI J,WANG C,et al.Intravenousadministration of tranexamic acid significantly reduces visible and hidden blood loss compared with its topical administration for dou-ble-segment posterior lumbar interbody fusion:a single-center,placebo-controlled,randomized trial[J].World Neurosurg,2019,122:e821-e827.
[39] 楊磊,饒耀劍,張昌盛,等.腰椎退變性側彎術中局部與靜脈應用氨甲環(huán)酸[J].中國矯形外科雜志,2020,28(15):1381-1384.
[40] LUO H,SHEN C,QU T,et al.Tranexamic acid-induced focal convulsions after spinal surgery:a rare case report and literature review on side effects of accidental spinal administration of tranexamic acid[J].EFORT Open Rev,2023,8(6):482-488.
[41] 王少杰,任蘭群.隱性失血的中醫(yī)病機探討[J].環(huán)球中醫(yī)藥,2017,10(4):465-467.
[42] 張江濤,謝欣序,崔亞茹,等.中藥多糖治療化療性骨髓抑制的藥理作用研究進展[J/OL].中華中醫(yī)藥學刊:1-18[2023-09-08]. http://kns.cnki.net/kcms/detail/21.1546.R.20230904.1508.002.html.
[43] 牛雪芳,廖奎,汪子鈴,等.當歸多糖促進骨髓移植小鼠造血功能重建及其機制研究[J].陸軍軍醫(yī)大學學報,2022,44(16):1621-1628.
[44] BAO W,ZHANG Q,ZHENG H,et al.Radix astragali polysaccharide RAP directly protects hematopoietic stem cells from chemotherapy-induced myelosuppression by increasing FOS expression[J].Int J Biol Macromol,2021,183:1715-1722.
[45] 雷蕾,李小陽,劉駿,等.化學功效組學:中藥現(xiàn)代研究的新方向——以止血藥和活血化瘀藥核心成分群研究為例[J].中國中藥雜志,2022,47(24):6803-6809.
[46] 向為民,徐無忌.加味桃紅四物湯治療腰椎后路椎體融合術后隱性失血的臨床研究[J].云南中醫(yī)中藥雜志,2023,44(2):53-56.
[47] 班正濤,李少榮,劉汝專,等.益血生膏方對腰椎后路椎間融合術術后隱性失血的影響[J].廣西中醫(yī)藥,2020,43(4):25-28.
[48] YOKOI H,CHAKRAVARTHY V,WINKLEMAN R,et al.Incorporation of blood and fluid management within an enhanced recovery after surgery protocol in complex spine surgery[J].Global Spine J,2022,23:21925682221120399.
[49] 鄧羅義,楊華,寧旭,等.腰椎后路手術患者隱性失血的影響因素[J].骨科臨床與研究雜志,2022,7(4):245-250.
[50] 柏天婷,冷楠楠,左瑩,等.營養(yǎng)狀況與髖部骨折圍手術期隱性失血的研究進展[J].聯(lián)勤軍事醫(yī)學,2023,37(2):171-175.
相似文獻/References:
[1]徐幫杰,楊楠,白偉杰,等.坐位定點旋轉整復法治療腰椎間盤突出癥的療效觀察[J].中醫(yī)正骨,2015,27(11):17.
XU Bangjie,YANG Nan,BAI Weijie,et al.Observation on the curative effect of fixed-point rotational reduction in sitting position in the treatment of lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):17.
[2]白春曉,賈育松,孫旗,等.中醫(yī)藥在腰椎間盤突出癥圍手術期應用的研究進展[J].中醫(yī)正骨,2015,27(11):65.
[3]王少純,周英杰.郭維淮教授運用活血益氣通經湯治療腰椎間盤突出癥的經驗[J].中醫(yī)正骨,2015,27(11):75.
[4]鄧紅軍.硫酸鈣骨水泥椎體成形聯(lián)合后路短節(jié)段椎弓根螺釘
內固定治療創(chuàng)傷性胸腰椎骨折[J].中醫(yī)正骨,2015,27(10):35.
[5]張莉,秦丹霞,張細姣.腹針治療椎間盤源性腰痛[J].中醫(yī)正骨,2015,27(10):38.
[6]蘇洪,張雪林.患側下肢牽引配合腰椎斜扳法治療
極外側型腰椎間盤突出癥[J].中醫(yī)正骨,2015,27(10):40.
[7]吳青坡,孫國紹,王林杰.后路椎管減壓聯(lián)合腰椎椎弓根釘動態(tài)穩(wěn)定裝置內固定
治療單節(jié)段腰椎退行性疾病[J].中醫(yī)正骨,2015,27(10):42.
[8]謝冬群,黃中梁,葉金麗.加強隔附子餅灸治療腎陽虛型腰椎間盤突出癥的
臨床研究[J].中醫(yī)正骨,2015,27(09):18.
XIE Dongqun,HUANG Zhongliang,YE Jinli.Clinical study on intensive aconite root cake separated moxibustion in the treatment of kidney-yang-deficiency-type lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):18.
[9]沈海良,錢萬鋒,周驍棟.針刀松解聯(lián)合局部封閉與口服中藥治療腰椎間盤突出癥[J].中醫(yī)正骨,2015,27(09):46.
[10]王仁燦,黃炎洪,潘偉江,等.45°肩踝懸吊牽引下撞擊腰椎療法治療L5S1椎間盤突出癥[J].中醫(yī)正骨,2015,27(08):51.
[11]王碩凡,陳哲,陳巖松.腰椎融合術后假關節(jié)形成的研究進展[J].中醫(yī)正骨,2017,29(07):51.
[12]郭營,梅偉.腰椎融合術后下肢疼痛的原因分析及治療[J].中醫(yī)正骨,2018,30(05):68.
[13]陳雙,吳奐汐,王楠,等.腰椎后路融合術后融合器沉降危險因素的Meta分析[J].中醫(yī)正骨,2022,34(10):44.
CHEN Shuang,WU Huanxi,WANG Nan,et al.A Meta-analysis of risk factors associated with cage subsidence after posterior lumbar interbody fusion[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(12):44.
[14]申素昊,孔鵬,汲長蛟,等.腰椎融合術后終板囊性變的研究進展[J].中醫(yī)正骨,2024,36(01):53.